ramelteon has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, L; Li, M; Qi, X; Shao, X; Tang, Z; Wang, J; Wang, Z; Yu, X; Zhang, X | 1 |
| Ahsan, A; Cao, M; Chen, JZ; Chen, Z; Hu, WW; Jiang, L; Liu, MR; Lu, SS; Tang, WD; Wu, JY; Wu, XL; Zhang, XN; Zheng, YR | 1 |
2 other study(ies) available for ramelteon and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Ramelteon improves blood-brain barrier of focal cerebral ischemia rats to prevent post-stroke depression via upregulating occludin.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Depression; Endothelial Cells; Infarction, Middle Cerebral Artery; Mice; Occludin; Rats; Reperfusion Injury; Stroke | 2023 |
Melatonin receptor agonist ramelteon attenuates mouse acute and chronic ischemic brain injury.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain; Brain Injury, Chronic; Edaravone; Indenes; Infarction, Middle Cerebral Artery; Mice; Neuroprotective Agents; Receptors, Melatonin; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |